InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
2
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the detailed record of transactions filed by Burnell Thomas W., Chief Executive Officer. Officer active across 1 company, notably Interpace Biosciences, INC.. Cumulatively, 2 disclosures have been recorded. Split: 2 buys · 0 sell. Total volume traded: €154k. Activity tracked since 21 May 2021. The latest transaction was filed on 21 May 2021 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Declarations2 total
10,855 shares@ US$8.680.16% mcap50.0% of flowCommon StockSEC:0001493152-21-012889:0
Ideal exit: 15 Feb 2022 (T+270)
10,855 shares@ US$8.6850.0% of flowCommon StockSEC:0001493152-21-012889
Ideal exit: 15 Feb 2022 (T+270)
2 of 2 declarations
About Burnell Thomas W.
Thomas W. Burnell is the President & CEO at INTERPACE BIOSCIENCES, INC. He is responsible for the overall direction of the company, overseeing operations and strategy. His leadership is essential to ensure the growth and success of the organization.
